by Team Small News | Dec 14, 2025 | Pharma, Piramal Pharma
The proposed US Biosecure Act, which aims to restrict certain biotech and pharmaceutical contracts involving China, could open up a significant opportunity for Indian contract development and manufacturing organizations (CDMOs) over the next few years. According to... by Team Small News | Dec 14, 2025 | Natco, Pharma
The article discusses the importance of considering debt when assessing a company’s risk, as stated by Charlie Munger, a renowned investor. Li Lu, a fund manager backed by Berkshire Hathaway, emphasizes that the biggest investment risk is not price volatility,...
by Team Small News | Dec 14, 2025 | Dr Reddy's
The US Food and Drug Administration (FDA) has approved two new oral medicines, Nuzolvence (zoliflodacin) and Blujepa (gepotidacin), to treat gonorrhea, a common sexually transmitted infection (STI) that is increasingly resistant to existing treatments. The World... by Team Small News | Dec 13, 2025 | Apollo Hospital, Pharma
Palm oil has been a topic of debate when it comes to health, with several misconceptions surrounding its use. To dispel these myths, Dr. Varun Bansal, a senior consultant cardiac surgeon at Indraprastha Apollo Hospitals, shared his insights on the common...
by Team Small News | Dec 13, 2025 | Pharma, Piramal Pharma
Piramal Pharma Limited, a leading pharmaceutical company, has been exhibiting remarkable growth patterns, making it an attractive investment opportunity. To determine if the company has competitive moats for long-term growth, it’s essential to analyze its...